Tag: Pharmaceuticals

Colchicine's Impact on Diabetes and Gout: Insights from NHIS Study

Discover findings from a NHIS study on colchicine's benefits for diabetes and gout patients, impacting health insurance practices and coverage strategies.

Medicare Negotiates New Pricing for Part D Medications, Impact on Drug Costs

Discover how Medicare's new drug pricing impacts beneficiaries and the health insurance landscape, with significant savings projected through 2027.

Increase in GLP-1RA Use Among Medicare Cancer Patients

A study reveals increased GLP-1RA usage among Medicare beneficiaries with cancer and diabetes, highlighting the need for inclusive research and equitable access.

CVS Health Expands Pharmacists' Roles for Chronic Disease Management

CVS Health is enhancing pharmacists' roles in chronic disease management, improving healthcare access and affordability, particularly for Medicare beneficiaries.

PhRMA Challenges Medicare's GLOBE Drug-Pricing Initiative

PhRMA's lawsuit against the U.S. government challenges CMS's new Medicare drug-pricing model, impacting costs and pharmaceutical innovation. Stay informed!

PhRMA Lawsuit Challenges Medicare Drug Price Program

PhRMA is suing the federal government over a new Medicare drug Pricing program. Understand implications for insurance professionals and the pharmaceutical market.

Allstate Sues Pharmacies Over No-Fault Insurance Fraud in New York

Allstate's lawsuits reveal alleged pharmacy fraud in New York's no-fault insurance system, raising significant concerns for the insurance industry and patient care.

California’s New Bill on Biosimilars: Potential Savings and Implications for Insurers

California's SB 1094 aims to lower healthcare costs with biosimilars, impacting insurance dynamics. Discover potential savings and implications for insurers.

Dompé U.S. Inc. Settles $32M Medicare Co-Pay Allegations

Dompé U.S. Inc. agrees to a $32 million settlement for illegal Medicare co-pay payments, raising critical compliance issues for insurance professionals in the industry.

Texas House Select Committee Addresses Escalating Healthcare Costs

The Texas House Select Committee discusses rising healthcare costs and strategies to enhance pricing transparency and improve rural healthcare access.